OC
CL icon

Oarsman Capital’s Colgate-Palmolive CL Stock Holding History

Oarsman Capital’s Portfolio CL Stock Details CL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$291K Hold
3,410
– – 0.04% 179
2025
Q4 		$269K Sell
3,410
-200
-6% -$15.7K 0.04% 191
2025
Q3 		$289K Hold
3,610
– – 0.04% 185
2025
Q2 		$328K Sell
3,610
-100
-3% -$9.13K 0.05% 173
2025
Q1 		$348K Hold
3,710
– – 0.06% 163
2024
Q4 		$337K Hold
3,710
– – 0.06% 166
2024
Q3 		$385K Hold
3,710
– – 0.07% 150
2024
Q2 		$360K Sell
3,710
-100
-3% -$9.22K 0.08% 155
2024
Q1 		$343K Sell
3,810
-100
-3% -$8.47K 0.08% 158
2023
Q4 		$312K Sell
3,910
-50
-1% -$3.76K 0.08% 166
2023
Q3 		$282K Sell
3,960
-3
-0.1% -$224 0.12% 139
2023
Q2 		$305K Sell
3,963
-197
-5% -$15.2K 0.13% 130
2023
Q1 		$313K Hold
4,160
– – 0.15% 127
2022
Q4 		$328K Hold
4,160
– – 0.17% 120
2022
Q3 		$292K Sell
4,160
-50
-1% -$3.92K 0.16% 132
2022
Q2 		$337K Sell
4,210
-1,206
-22% -$94.3K 0.17% 129
2022
Q1 		$411K Buy
5,416
+1,100
+25% +$87.1K 0.16% 132
2021
Q4 		$368K Sell
4,316
-1,394
-24% -$109K 0.15% 137
2021
Q3 		$432K Sell
5,710
-260
-4% -$20.6K 0.17% 129
2021
Q2 		$486K Sell
5,970
-50
-0.8% -$4.09K 0.19% 123
2021
Q1 		$475K Sell
6,020
-830
-12% -$65.1K 0.21% 119
2020
Q4 		$586K Sell
6,850
-700
-9% -$57.9K 0.23% 104
2020
Q3 		$582K Sell
7,550
-500
-6% -$38.1K 0.26% 93
2020
Q2 		$590K Buy
8,050
+4,370
+119% +$310K 0.29% 83
2020
Q1 		$244K Sell
3,680
-5,285
-59% -$373K 0.23% 94
2019
Q4 		$617K Sell
8,965
-300
-3% -$20.5K 0.28% 89
2019
Q3 		$681K Sell
9,265
-50
-0.5% -$3.63K 0.32% 83
2019
Q2 		$668K Sell
9,315
-925
-9% -$65.7K 0.3% 84
2019
Q1 		$702K Sell
10,240
-370
-3% -$23.9K 0.33% 83
2018
Q4 		$632K Sell
10,610
-400
-4% -$25K 0.32% 91
2018
Q3 		$737K Sell
11,010
-100
-0.9% -$6.66K 0.3% 91
2018
Q2 		$720K Sell
11,110
-900
-7% -$58.9K 0.33% 89
2018
Q1 		$861K Sell
12,010
-1,282
-10% -$92.3K 0.39% 83
2017
Q4 		$1M Sell
13,292
-625
-4% -$45.6K 0.43% 72
2017
Q3 		$1.01M Buy
13,917
+730
+6% +$52.6K 0.43% 75
2017
Q2 		$978K Sell
13,187
-1,580
-11% -$117K 0.45% 75
2017
Q1 		$1.08M Buy
14,767
+1,940
+15% +$136K 0.5% 69
2016
Q4 		$839K Sell
12,827
-3,384
-21% -$232K 0.54% 65
2016
Q3 		$1.2M Sell
16,211
-243
-1% -$18K 0.61% 56
2016
Q2 		$1.2M Sell
16,454
-310
-2% -$22.1K 0.63% 54
2016
Q1 		$1.18M Sell
16,764
-352
-2% -$23.4K 0.63% 56
2015
Q4 		$1.14M Sell
17,116
-1,212
-7% -$80.6K 0.64% 58
2015
Q3 		$1.16M Sell
18,328
-4,656
-20% -$304K 0.69% 52
2015
Q2 		$1.5M Hold
22,984
– – 1.03% 30
2015
Q1 		$1.59M Buy
22,984
+85
+0.4% +$5.88K 1.1% 27
2014
Q4 		$1.58M Sell
22,899
-195
-0.8% -$13.2K 1.14% 24
2014
Q3 		$1.51M Buy
23,094
+71
+0.3% +$4.68K 1.11% 25
2014
Q2 		$1.57M Buy
23,023
+100
+0.4% +$6.7K 1.14% 22
2014
Q1 		$1.49M Sell
22,923
-397
-2% -$25K 1.15% 23
2013
Q4 		$1.52M Sell
23,320
-100
-0.4% -$6.4K 1.22% 20
2013
Q3 		$1.39M Sell
23,420
-255
-1% -$15.1K 1.21% 19
2013
Q2 		$1.36M Buy
+23,675
New +$1.41M 1.28% 18

Other funds holding CL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DAM
Diamant Asset Management Ridgefield, Connecticut $137B AUM 18.02% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Oarsman Capital's CL Position: Q1 2026 in Review

Oarsman Capital held its Colgate-Palmolive (CL) position steady in Q1 2026 at 3,410 shares worth $291K. The position accounts for 0.04% of the portfolio, ranked #179.

Oarsman Capital first reported a position in CL in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.59M in Q1 2015. 1,945 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Oarsman Capital held 3,410 shares of Colgate-Palmolive worth $291K as of Q1 2026.
  • Oarsman Capital left its Colgate-Palmolive share count unchanged in Q1 2026.
  • Colgate-Palmolive made up 0.04% of Oarsman Capital's portfolio in Q1 2026, its #179 holding.
  • Oarsman Capital first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • Oarsman Capital's Colgate-Palmolive position peaked at $1.59M in Q1 2015.
  • 1,945 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Oarsman Capital's 13F filing for Q1 2026, filed 28 Apr 2026.